Long-term structural failure of coaxial polyurethane implantable cardioverter defibrillator leads

被引:37
作者
Hauser, RG
Cannom, D
Hayes, DL
Parsonnet, V
Hayes, J
Ratliff, N
Tyers, GFO
Epstein, AE
Vlay, SC
Furman, S
Gross, J
机构
[1] Minneapolis Heart Inst Fdn, Minneapolis, MN USA
[2] Good Samaritan Hosp, Los Angeles, CA USA
[3] Mayo Clin, Rochester, MN USA
[4] Newark Beth Israel, Newark, NJ USA
[5] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI USA
[6] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[7] Univ Alabama Birmingham, Birmingham, AL USA
[8] Univ Hosp Stony Brook, Stony Brook, NY USA
[9] Montefiore Med Ctr, Bronx, NY 10467 USA
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 2002年 / 25卷 / 06期
关键词
implantable cardioverter defibrillator; leads; complications; registry;
D O I
10.1046/j.1460-9592.2002.t01-1-00879.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Transvene models 693616966, a coaxial polyurethane ICD lead, may be prone to structural failure. These models comprise 54% of ICD lead failures in the authors' Multicenter Registry database. Because ICD leads perform a vital function, the clinical features, causes, and probability of Transvene 693616966 lead failure were determined. The Registry and United States Food and Drug Administration databases were queried for the clinical features and structural causes of the Transvene 693616966 lead failure, and a five-center substudy estimated the survival probability for 521 Transvene 6936/6966 implants. The mean time to failure was 4.8 +/- 2.1 years, and the estimated survival at 60 and 84 months after implant were 92% and 84%, respectively. Oversensing was the most common sign of failure (76%), and 24 patients experienced inappropriate shocks. The manufacturer's reports indicated that high voltage coil fracture and 80A polyurethane defects were the predominant causes of lead failure. Transvene models 6936 and 6966 coaxial polyurethane ICD leads are prone to failure over time. Patients who have these leads should be evaluated frequently, Additional studies are needed to identify safe management strategies.
引用
收藏
页码:879 / 882
页数:4
相关论文
共 50 条
  • [41] Failure of a novel silicone-polyurethane copolymer (Optim™) to prevent implantable cardioverter-defibrillator lead insulation abrasions
    Hauser, Robert G.
    Abdelhadi, Raed H.
    McGriff, Deepa M.
    Retel, Linda Kallinen
    EUROPACE, 2013, 15 (02): : 278 - 283
  • [42] Implantable cardioverter-defibrillators: a long-term view
    Wilson, D.
    Shi, B.
    Harding, S.
    Lever, N.
    Larsen, P.
    INTERNAL MEDICINE JOURNAL, 2012, 42 (05) : 554 - 561
  • [43] "Home monitoring" for early detection of implantable cardioverter-defibrillator failure
    Hauck, Melanie
    Bauer, Alexander
    Voss, Frederik
    Weretka, Slawomir
    Katus, Hugo A.
    Becker, Ruediger
    CLINICAL RESEARCH IN CARDIOLOGY, 2009, 98 (01) : 19 - 24
  • [44] Long-term quality of life and acceptance of implantable cardioverter-defibrillator therapy: results of the European Heart Rhythm Association survey
    Januszkiewicz, Lukasz
    Barra, Sergio
    Providencia, Rui
    Conte, Giulio
    de Asmundis, Carlo
    Chun, Julian K. R.
    Farkowski, Michal M.
    Guerra, Jose M.
    Marijon, Eloi
    Boveda, Serge
    EUROPACE, 2022, 24 (05): : 860 - 867
  • [45] Incidence of complications in patients with implantable cardioverter/defibrillator who receive additional transvenous pace/sense leads
    Wollmann, CG
    Böcker, D
    Löher, A
    Köbe, J
    Scheld, HH
    Breithardt, GE
    Gradaus, R
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2005, 28 (08): : 795 - 800
  • [46] Cardiac Sarcoidosis: Electrophysiological Outcomes on Long-Term Follow-Up and the Role of the Implantable Cardioverter-Defibrillator
    Mohsen, Amr
    Jimenez, Alejandro
    Hood, Robert E.
    Dickfeld, Timm
    Saliaris, Anastasios
    Shorofsky, Stephen
    Saba, Magdi M.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2014, 25 (02) : 171 - 176
  • [47] Long-term follow-up study of uncertainty and psychosocial adjustment among implantable cardioverter defibrillator recipients
    Mauro, Ann Marie P.
    INTERNATIONAL JOURNAL OF NURSING STUDIES, 2010, 47 (09) : 1080 - 1088
  • [48] Long-Term Follow-Up of Implantable Cardioverter-Defibrillator for Secondary Prevention in Chagas' Heart Disease
    Martinelli, Martino
    de Siqueira, Sergio Freitas
    Sternick, Eduardo Back
    Rassi, Anis, Jr.
    Costa, Roberto
    Franchini Ramires, Jose Antonio
    Kalil Filho, Roberto
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (07) : 1040 - 1045
  • [49] Incidence, Management, and Prevention of Right Ventricular Perforation by Pacemaker and Implantable Cardioverter Defibrillator Leads
    Migliore, Federico
    Zorzi, Alessandro
    Bertaglia, Emanuele
    Leoni, Loira
    Siciliano, Mariachiara
    De Lazzari, Manuel
    Ignatiuk, Barbara
    Veronese, Marta
    Verlato, Roberto
    Tarantini, Giuseppe
    Iliceto, Sabino
    Corrado, Domenico
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2014, 37 (12): : 1602 - 1609
  • [50] Applicability of a Risk Score for Prediction of the Long-Term (8-Year) Benefit of the Implantable Cardioverter-Defibrillator
    Barsheshet, Alon
    Moss, Arthur J.
    Huang, David T.
    McNitt, Scott
    Zareba, Wojciech
    Goldenberg, Ilan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (23) : 2075 - 2079